COVID-19 Resources Archives | Frier Levitt

The “Reverse” False Claim: A Cautionary Tale for Providers with Lax Compliance

Abdul J. Roberts, Esq., Guillermo J. Beades, Esq. and Jason N. Silberberg, Esq. April 29, 2021

With the onset of the pandemic and the flood of claims submitted by providers to government payors in connection with it – such as claims for COVID testing or upwardly (risk) adjusted PMPM capitation payments – comes substantial risk for the... Read More

Employment Law Alert: Employee Challenges Constitutionality of New Mexico County Directive Requiring All First Responders To Receive COVID-19 Vaccine

Sean E. Sanders, Esq. and Michelle L. Greenberg, Esq. April 29, 2021

In what may be the first of many lawsuits, a New Mexico county prison guard has filed a lawsuit challenging a directive requiring all first responders to receive a COVID-19 vaccine as a condition of continued employment. The lawsuit is particularly... Read More

Lessons Learned from the First Wave of COVID-19: How to Navigate the Second Wave and Implement Lasting Changes to Benefit your Practice On Demand Webinar Replay

Frier Levitt April 15, 2021

Frier Levitt is proud to offer a complimentary webinar replay recapping the lessons healthcare practices should learn from the first wave of the COVID-19 pandemic that could help them both navigate the second wave and implement meaningful changes... Read More

COVID-19 Resources | Webinars

COVID-19 Vaccine Alert: CMS Increases Payment Rates for COVID-19 Vaccinations

Jesse C. Dresser, Esq. and Jessica L. Missel, J.D. April 1, 2021

We previously highlighted CMS’s pharmacy reimbursement rates for administration of the COVID-19 vaccine. At that time, CMS detailed the Medicare payment rates for COVID-19 vaccine administration were $28.39 to administer single-dose vaccines and... Read More

Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences

Private Equity Investment in Specialty Pharmacies – How DIR Fees May Affect a Pharmacy’s Value (and What Prospective Investors Can Do)

Jesse C. Dresser, Esq., Steven L. Bennet, Esq. and A.J. Barbarito, Esq. March 30, 2021

The specialty pharmacy space has proven to be a rewarding investment for private equity, as specialty medications typically lead the pharmacy trend cost curve, which will only continue as more than 60 new specialty medications expected to receive... Read More

What is the Long-Term Future of Long-Term Care Facilities and Nursing Homes after COVID-19?

Guillermo J. Beades, Esq. and Abdul J. Roberts, Esq. March 17, 2021

The pandemic took a toll on nursing homes and long-term care facilities. The industry is being subjected to heighten scrutiny after the COVID-19 pandemic exposed, among other things, some of the problems with long-term care resources. News... Read More

Blogs & Articles | COVID-19 Resources | Healthcare | Skilled Nursing Facilities and Long-Term

COVID-19: Additional Guidance on Pharmacy Vaccine Administration

Jessica L. Missel, J.D. and Jesse C. Dresser, Esq. March 1, 2021

The Food and Drug Administration (FDA) issued emergency use authorization for three vaccines to protect against COVID-19. While these long-awaited vaccines have provided tremendous hope for the nation in looking for a pathway out of the pandemic,... Read More

Lessons Learned from the First Wave of COVID-19: How to Navigate the Second Wave and Implement Lasting Changes to Benefit your Practice

Guillermo J. Beades, Esq., Wiks Moffat, CHC, Jim Tudor, PCA, CPC and Frier Levitt February 1, 2021

by Guillermo Beades, Esq. of Frier Levitt, LLC, Wiks Moffat, CHC, of HealthCare Compliance Network, LLC, and Jim Tudor, PCA, CPC, of HealthCare Compliance Network, LLC When the COVID-19 pandemic reached our shores, it instantly changed the way we... Read More

Blogs & Articles | COVID-19 Resources | Telehealth and Telemedicine

NJ Employers Weigh Vaccine Rules Against Legal Liability

Jesse C. Dresser, Esq. January 29, 2021

Frier Levitt Life Sciences Partner Jesse Dresser, Esq., who heads the Firm's Pharmacy Practice Group, recently spoke to Law360 about "NJ Employers Weigh Vaccine Rules Against Legal Liability." Jesse says that "he's seeing more educational... Read More

Blogs & Articles | COVID-19 Resources | Employment Matters | Life Sciences

Pharmacy ALERT: CVS Caremark Nearly Doubles Drugs on “Aberrant Quantities” Product List Effective January 2021

Dae Y. Lee, Esq., Pharm.D CPBS and Harini Bupathi, Esq. January 7, 2021

In 2019, Frier Levitt reported a new dispensing limitation CVS Caremark (“Caremark”) introduced in its retail networks that took effect on January 1, 2020. Specifically, Caremark issued an “Aberrant Product List” that identified... Read More